home · filing · 0001104659-23-023228
8-K filed February 17, 2023, 6:59 PM ET
ticker VREOF
CIK 0001771706
leadership
confidence high
sentiment neutral
materiality 0.75
Goodness Growth appoints Joshua Rosen interim CEO; founder Kingsley becomes Executive Chairman
Vireo Growth Inc.
Founder Dr. Kyle Kingsley resigns as CEO, becomes Executive Chairman; base compensation set at $260k/yr (severance calculated at $360k base).
Joshua Rosen appointed interim CEO; previously interim President and board member since Aug 2021.
Amber Shimpa promoted to President of Goodness Growth and CEO of Vireo Health of Minnesota; she is Kingsley's sister-in-law.
Reorganization decentralizes operations to state-level teams to drive improved financial performance.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Role change
Kyle Kingsley
Executive Chairman
VREOF ·
Vireo Growth Inc.
Effective 2023-02-14
Successor Joshua Rosen
Filed February 17, 2023, 6:59 PM ET
Dr. Kyle E. Kingsley, age 47, has been appointed to the position of Executive Chairman and has resigned the position of Chief Executive Officer
Appointed
(interim)
Joshua Rosen
Interim CEO
VREOF ·
Vireo Growth Inc.
Effective 2023-02-14
Filed February 17, 2023, 6:59 PM ET
On February 14, 2023, the Registrant announced the appointment of Joshua Rosen, age 49, as interim CEO of each of the Registrant and VHI.
Appointed
Amber Shimpa
President
VREOF ·
Vireo Growth Inc.
Effective 2023-02-14
Filed February 17, 2023, 6:59 PM ET
the appointment of Amber Shimpa, age 44, to the position of President of each of the Registrant and VHI.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kyle Kingsley was appointed as Executive Chairman at Vireo Growth Inc..
Action appointed
Role Executive Chairman
Exact text from the filing
Dr. Kyle E. Kingsley, age 47, has been appointed to the position of Executive Chairman and has resigned the position of Chief Executive Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Joshua Rosen was appointed as Interim CEO at Vireo Growth Inc..
Action appointed
Role Interim CEO
Exact text from the filing
On February 14, 2023, the Registrant announced the appointment of Joshua Rosen, age 49, as interim CEO of each of the Registrant and VHI.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Amber Shimpa was appointed as President at Vireo Growth Inc..
Action appointed
Role President
Exact text from the filing
the appointment of Amber Shimpa, age 44, to the position of President of each of the Registrant and VHI.
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-23-023228
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.